Product Description
Brand Mindray
Sample Type Serum
Pack Size 2 x 50T, 2 x 100T
CAT No 10500421500, 10500424200
Application Immuno-Assay
Ourchemiluminescence immunoassay reagentshave been specially developed to work with Mindrays CL series automatic chemiluminescence immunoassay analyzers to make a complete system, offering high reliability and accuracy. Mindray uses liquid, ready-to-use reagents which come in two packages, 50 tests and 100 tests, to suit customers with different requirements.
Reliable Ovarian Cancer DiagnosticsEnsure early and precise detection of ovarian cancer and related malignancies using Mindrays CA125 reagent. The assay leverages advanced CLIA technology for high sensitivity and specificity, providing healthcare professionals with confidence in their diagnostic results. Its rapid turnaround time supports timely clinical decision-making and patient management.
Seamless Integration and OperationMindray CA125 CLIA kits are fully compatible with Mindray CL-series Chemiluminescence Immunoassay analyzers, ensuring effortless integration into existing laboratory workflows. The automated, real-time operation, combined with silent performance, makes this reagent kit a convenient and efficient solution for modern laboratories. The kit requires minimal sample volume and comes with all necessary components for immediate use.
Quality and Compliance AssuredEach kit is manufactured with diagnostic-grade materials, CE-marked, and IVD certified, meeting strict quality and regulatory standards. The lot-specific calibration ensures result accuracy, while clear expiry details and storage guidelines help maintain reagent performance throughout its 12-month shelf life. The reagents stability and high measurement range further enhance its reliability in clinical use.
FAQs of Mindray Cancer Antigen 125 (CLIA):
Q: How is the Mindray CA125 (CLIA) kit used in ovarian cancer diagnostics?
A: The Mindray CA125 (CLIA) kit is used for the quantitative determination of Cancer Antigen 125 (CA125) in human serum or plasma samples, aiding in the diagnosis and monitoring of ovarian cancer and related malignancies. Clinicians use this test to evaluate CA125 levels, which can indicate the presence or progression of disease.
Q: What sample type and volume are required for the CA125 assay?
A: The assay requires either human serum or plasma. The required sample volume ranges from 10 to 50 L, depending on the Mindray CL-series analyzer model being used.
Q: When should lot-specific calibration be performed?
A: Lot-specific calibration must be carried out each time a new kit lot is used, ensuring the accuracy and reliability of results specific to the reagent batch.
Q: Where can the Mindray CA125 (CLIA) kit be used?
A: This CE and IVD certified kit is intended for use in clinical laboratories and hospitals equipped with Mindray CL-series Chemiluminescence Immunoassay systems throughout India and internationally.
Q: What is the process for performing the assay with this kit?
A: The process involves loading the CA125 reagent, calibrators, and controls into the compatible analyzer, preparing the patient sample (serum or plasma), and running the automated protocol. Results are typically available within 1545 minutes, depending on the analyzer.
Q: How should the CA125 reagent kit be stored to maintain performance?
A: Store the kit at 28C and protect it from light. Always refer to the expiry date printed on the packaging and avoid using the kit beyond this period to ensure optimal reagent stability.
Q: What are the main benefits of using this kit?
A: Key benefits include high sensitivity and specificity, rapid and automated assay time, minimal sample requirement, high measurement range (0500 U/mL), and compatibility with Mindray CL-series analyzers. Its ready-to-use format streamlines workflow, making the kit suitable for high-throughput clinical and laboratory environments.